DK3532072T3 - Behandling af glaukom - Google Patents
Behandling af glaukom Download PDFInfo
- Publication number
- DK3532072T3 DK3532072T3 DK18727467.5T DK18727467T DK3532072T3 DK 3532072 T3 DK3532072 T3 DK 3532072T3 DK 18727467 T DK18727467 T DK 18727467T DK 3532072 T3 DK3532072 T3 DK 3532072T3
- Authority
- DK
- Denmark
- Prior art keywords
- glaucum
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1750615 | 2017-05-17 | ||
| US201762555848P | 2017-09-08 | 2017-09-08 | |
| PCT/SE2018/050506 WO2018212708A1 (en) | 2017-05-17 | 2018-05-16 | Treatment of glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3532072T3 true DK3532072T3 (da) | 2020-04-06 |
Family
ID=62245395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18727467.5T DK3532072T3 (da) | 2017-05-17 | 2018-05-16 | Behandling af glaukom |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11291684B2 (da) |
| EP (1) | EP3532072B1 (da) |
| JP (1) | JP6817466B2 (da) |
| KR (1) | KR102331421B1 (da) |
| CN (1) | CN110621320B (da) |
| BR (1) | BR112019024087A2 (da) |
| CA (1) | CA3063851C (da) |
| DK (1) | DK3532072T3 (da) |
| ES (1) | ES2777836T3 (da) |
| IL (1) | IL270362B (da) |
| PL (1) | PL3532072T3 (da) |
| PT (1) | PT3532072T (da) |
| RU (1) | RU2759998C2 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111263636A (zh) * | 2017-09-08 | 2020-06-09 | Tx医生公司 | 硫酸葡聚糖的新用途 |
| GB202008919D0 (en) * | 2020-06-11 | 2020-07-29 | Univ Birmingham | Polysaccharide conpositions and therapeutic gels |
| CN115531417B (zh) * | 2022-11-14 | 2024-04-09 | 青岛海尔生物科技有限公司 | ITGA6阳性iPSC源小梁网类细胞在制备治疗高眼压疾病药物中的应用及筛选方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4238482A (en) | 1978-09-29 | 1980-12-09 | Peyman Gholam A | Intraocular infusion irrigation solution and method |
| DE3705669A1 (de) | 1987-02-21 | 1988-09-01 | Thomae Gmbh Dr K | Verwendung von dextransulfat zur herstellung eines arzneimittels zur behandlung und prophylaxe von gefaessverengungen und gefaessverschluessen |
| JPH02223525A (ja) * | 1988-11-16 | 1990-09-05 | Takeda Chem Ind Ltd | 血管新生阻害剤 |
| US5135920A (en) * | 1988-11-16 | 1992-08-04 | Takeda Chemical Industries, Ltd. | Angiostatic agents |
| US5227372A (en) | 1990-03-07 | 1993-07-13 | Children's Medical Center Corporation | Method for retaining ophthalmological agents in ocular tissues |
| CA2020199C (en) | 1990-06-29 | 2002-08-20 | Daniel Bar-Shalom | Uses of sulphated sugars |
| US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| AU3980499A (en) | 1998-05-11 | 1999-11-29 | Endowment for Research in Human Biology, Inc., The | Use of neomycin for treating angiogenesis-related diseases |
| GB9917092D0 (en) | 1999-07-22 | 1999-09-22 | Ml Lab Plc | Treatment of angiogenesis-dependent conditions |
| WO2005110438A2 (en) | 2004-04-15 | 2005-11-24 | Massachusetts Institute Of Technology | Methods and products related to the intracellular delivery of polysaccharides |
| SE0401182D0 (sv) | 2004-05-05 | 2004-05-05 | Q Med Ab | Novel use of a viscoelastic composition |
| US20060154894A1 (en) | 2004-09-15 | 2006-07-13 | Massachusetts Institute Of Technology | Biologically active surfaces and methods of their use |
| US20090220516A1 (en) * | 2005-06-22 | 2009-09-03 | Alan Laties | Neuroprotection of retinal ganglion cells |
| US20140186339A1 (en) | 2006-10-27 | 2014-07-03 | Lpath, Inc. | Compositions and methods for treating ocular diseases and conditions |
| US20130273096A1 (en) | 2011-10-05 | 2013-10-17 | Bruce A. Daniels | Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients |
| CN106714820A (zh) * | 2014-05-12 | 2017-05-24 | 普渡研究基金会 | 选择素及icam/vcam肽配体偶联物 |
| WO2015190989A1 (en) | 2014-06-12 | 2015-12-17 | Tx Medic Ab | The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject |
| SE538503C2 (en) * | 2014-11-11 | 2016-08-16 | Tx Medic Ab | New dextran sulfate |
| SE539575C2 (en) * | 2015-07-30 | 2017-10-17 | Tx Medic Ab | Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis |
| CN107137421A (zh) | 2017-05-25 | 2017-09-08 | 青岛市中心医院 | 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用 |
-
2018
- 2018-05-16 PL PL18727467T patent/PL3532072T3/pl unknown
- 2018-05-16 US US16/614,279 patent/US11291684B2/en active Active
- 2018-05-16 KR KR1020197033872A patent/KR102331421B1/ko active IP Right Grant
- 2018-05-16 CN CN201880031854.2A patent/CN110621320B/zh active Active
- 2018-05-16 EP EP18727467.5A patent/EP3532072B1/en active Active
- 2018-05-16 ES ES18727467T patent/ES2777836T3/es active Active
- 2018-05-16 BR BR112019024087-0A patent/BR112019024087A2/pt unknown
- 2018-05-16 RU RU2019136633A patent/RU2759998C2/ru active
- 2018-05-16 PT PT187274675T patent/PT3532072T/pt unknown
- 2018-05-16 CA CA3063851A patent/CA3063851C/en active Active
- 2018-05-16 DK DK18727467.5T patent/DK3532072T3/da active
- 2018-05-16 JP JP2019563248A patent/JP6817466B2/ja active Active
-
2019
- 2019-10-31 IL IL270362A patent/IL270362B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20210315920A1 (en) | 2021-10-14 |
| RU2019136633A (ru) | 2021-06-17 |
| JP2020519742A (ja) | 2020-07-02 |
| PL3532072T3 (pl) | 2020-09-21 |
| PT3532072T (pt) | 2020-03-05 |
| BR112019024087A2 (pt) | 2020-06-02 |
| KR102331421B1 (ko) | 2021-11-25 |
| CN110621320A (zh) | 2019-12-27 |
| CA3063851C (en) | 2023-09-19 |
| CN110621320B (zh) | 2023-03-17 |
| KR20200005560A (ko) | 2020-01-15 |
| JP6817466B2 (ja) | 2021-01-20 |
| EP3532072B1 (en) | 2020-01-01 |
| RU2759998C2 (ru) | 2021-11-22 |
| US11291684B2 (en) | 2022-04-05 |
| CA3063851A1 (en) | 2018-11-22 |
| EP3532072A1 (en) | 2019-09-04 |
| ES2777836T3 (es) | 2020-08-06 |
| RU2019136633A3 (da) | 2021-06-17 |
| IL270362B (en) | 2021-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3570844T3 (da) | Azolopyrimidin til behandlingen af kræftrelaterede lidelser | |
| DK3134530T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3288581T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK3777855T3 (da) | Fremgangsmåder til behandling af fibrotiske sygdomme | |
| DK3728271T3 (da) | Makrocykliske forbindelser til behandling af sygdomme | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3554240T3 (da) | Kombinationer af aktive forbindelser | |
| DK3458052T3 (da) | Kombinationsbehandling af cancer | |
| DK3461891T3 (da) | Nedstrømsbehandling af en alkalisk phosphatase | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3506904T3 (da) | Behandling af demens | |
| DK3318115T3 (da) | Maskine til behandling af svinegylle | |
| DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner | |
| DK3569166T3 (da) | Indretning til akut behandling af hjertestop | |
| DK3368044T3 (da) | Behandling af hepatisk steatose-relateret oligo-ovulation | |
| DK3525774T3 (da) | Lasofoxifen behandling af er+ brystcancer | |
| DK3548061T3 (da) | Behandling af neurologiske sygdomme | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| DK3532076T3 (da) | Immunterapeutiske behandlinger af tumorer | |
| DK3151814T3 (da) | Behandling af en hudlæsion | |
| DK3532072T3 (da) | Behandling af glaukom | |
| DK3743064T3 (da) | Behandling af proteinuri | |
| TWI800561B (zh) | 毛髮處理方法 | |
| DK3678644T3 (da) | Formuleringer af copanlisib |